Robert Nelsen - Jun 6, 2024 Form 4/A Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director, 10%+ Owner
Signature
/s/ Julie Shah, Attorney-in-Fact for Robert Nelsen
Stock symbol
SANA
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4/A
Date filed
7/15/2024, 04:12 PM
Date Of Original Report
Jun 7, 2024
Previous filing
Jun 3, 2024
Next filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +65K $0.00 65K Jun 6, 2024 Common Stock 65K $7.36 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired.
F2 The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.